Assured Screening is expanding its network of clinical partners and resellers to facilitate the sampling needs of businesses, individuals and public health systems throughout the UK and Ireland. These include private GP practices, clinics, pharmacies, workforce occupational health teams etc.
Enabling high accuracy, rapid turnaround COVID-19 testing service across the UK and Ireland for back-to-work plans and business risk management strategies.
For partners, your existing and new customers can now access the test with a best in class performance.
PARTNER WITH US
We are partnering with private GPs, Occupational Health Organisations, Pharmacies, Phlebotomists and Healthcare providers throughout the UK and Ireland to help provide sought-after testing.
Contact us if you have the capability to be part of our Clinical Test Network.
Honeyman operates a UK and Ireland Logistics network to transport samples to our facility, with results typically returned within 24 hours. This presents a great opportunity for our partners to help get businesses back to work.
Our testing facility in Barnard Castle requires channel partners to provide phlebotomy and patient services.
We are encouraging our partners to focus on helping:
Chief Executive Officer, Quotient
Antibody testing – the ability to quickly test if people have developed antibodies to COVID-19– is critical in helping the UK move out of lockdown, restarting the economy and continuing to fight this pandemic. We are proud to be working with Honeyman.
MD, Assured Screening
Existing approved test methods used within the UK provide for IgG antibody detection only, but research has shown that not everyone has this reaction. Quotient’s MosaiQ™ COVID-19 Antibody Microarray additionally picks-up the instances in which people have an IgM response.
Chief Operating Officer, Quotient
MosaiQ was developed in the UK, in Edinburgh, and Switzerland and we believe it is one of the most accurate and fastest tests on the market. We are talking to Governments and laboratories across the Continent and are delighted about the positive response we have been getting.